195 related articles for article (PubMed ID: 8626409)
61. Direct photoaffinity labeling by dolastatin 10 of the amino-terminal peptide of beta-tubulin containing cysteine 12.
Bai R; Covell DG; Taylor GF; Kepler JA; Copeland TD; Nguyen NY; Pettit GR; Hamel E
J Biol Chem; 2004 Jul; 279(29):30731-40. PubMed ID: 15123603
[TBL] [Abstract][Full Text] [Related]
62. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
63. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
64. Molecular mechanism of colchicine action: induced local unfolding of beta-tubulin.
Sackett DL; Varma JK
Biochemistry; 1993 Dec; 32(49):13560-5. PubMed ID: 8257691
[TBL] [Abstract][Full Text] [Related]
65. Selenium: inhibition of microtubule formation and interaction with tubulin.
Leynadier D; Peyrot V; Codaccioni F; Briand C
Chem Biol Interact; 1991; 79(1):91-102. PubMed ID: 1647889
[TBL] [Abstract][Full Text] [Related]
66. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
67. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
Vidya R; Eggen M; Georg GI; Himes RH
Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
[TBL] [Abstract][Full Text] [Related]
68. Concerning the chemical nature of tubulin subunits that cap and stabilize microtubules.
Caplow M; Fee L
Biochemistry; 2003 Feb; 42(7):2122-6. PubMed ID: 12590601
[TBL] [Abstract][Full Text] [Related]
69. Rhizoxin binding to tubulin at the maytansine-binding site.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
[TBL] [Abstract][Full Text] [Related]
70. HMBA depolymerizes microtubules, activates mitotic checkpoints and induces mitotic block in MCF-7 cells by binding at the colchicine site in tubulin.
Chatterji BP; Banerjee M; Singh P; Panda D
Biochem Pharmacol; 2010 Jul; 80(1):50-61. PubMed ID: 20302847
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of the cytotoxic mechanism mediated by baccatin III, the synthetic precursor of taxol.
Pengsuparp T; Kingston DG; Neidigh KA; Cordell GA; Pezzuto JM
Chem Biol Interact; 1996 Aug; 101(2):103-14. PubMed ID: 8760392
[TBL] [Abstract][Full Text] [Related]
72. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.
Batra JK; Powers LJ; Hess FD; Hamel E
Cancer Res; 1986 Apr; 46(4 Pt 2):1889-93. PubMed ID: 3948171
[TBL] [Abstract][Full Text] [Related]
73. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
74. Polymerization of the tubulin-colchicine complex: relation to microtubule assembly.
Andreu JM; Wagenknecht T; Timasheff SN
Biochemistry; 1983 Mar; 22(7):1556-66. PubMed ID: 6849866
[TBL] [Abstract][Full Text] [Related]
75. The cryptophycin-tubulin ring structure indicates two points of curvature in the tubulin dimer.
Watts NR; Cheng N; West W; Steven AC; Sackett DL
Biochemistry; 2002 Oct; 41(42):12662-9. PubMed ID: 12379108
[TBL] [Abstract][Full Text] [Related]
76. Methylenedioxy-benzopyran analogs of podophyllotoxin, a new synthetic class of antimitotic agents that inhibit tubulin polymerization.
Batra JK; Kang GJ; Jurd L; Hamel E
Biochem Pharmacol; 1988 Jul; 37(13):2595-602. PubMed ID: 3390218
[TBL] [Abstract][Full Text] [Related]
77. Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.
Rashid A; Kuppa A; Kunwar A; Panda D
Biochemistry; 2015 Mar; 54(12):2149-59. PubMed ID: 25747795
[TBL] [Abstract][Full Text] [Related]
78. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Jordan A; Hadfield JA; Lawrence NJ; McGown AT
Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
[TBL] [Abstract][Full Text] [Related]
79. Thermodynamic and structural analysis of microtubule assembly: the role of GTP hydrolysis.
Vulevic B; Correia JJ
Biophys J; 1997 Mar; 72(3):1357-75. PubMed ID: 9138581
[TBL] [Abstract][Full Text] [Related]
80. Vinblastine-induced aggregation of brine shrimp (Artemia) tubulin.
Mackinlay SA; Ludueña RF; MacRae TH
Biochim Biophys Acta; 1986 Jul; 882(3):419-26. PubMed ID: 3730421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]